about
Immunopositivity for histone macroH2A1 isoforms marks steatosis-associated hepatocellular carcinomaThe endothelium abridges insulin resistance to premature agingMandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/CDefects of the insulin receptor substrate (IRS) system in human metabolic disordersEctodomain shedding of EGFR ligands and TNFR1 dictates hepatocyte apoptosis during fulminant hepatitis in miceDysfunctional dopaminergic neurotransmission in asocial BTBR mice.Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritisSildenafil reduces insulin-resistance in human endothelial cellsAge-related different relationships between ectopic adipose tissues and measures of central obesity in sedentary subjects.Adiponectin isoforms in elderly patients with or without coronary artery disease.The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: evidence for interaction with obesity in diabetic patients.Joint effect of insulin signaling genes on all-cause mortality.ITCH modulates SIRT6 and SREBP2 to influence lipid metabolism and atherosclerosis in ApoE null mice.Decreased IRS2 and TIMP3 expression in monocytes from offspring of type 2 diabetic patients is correlated with insulin resistance and increased intima-media thickness.Pharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse.TIMP3 interplays with apelin to regulate cardiovascular metabolism in hypercholesterolemic mice.TAp73 depletion accelerates aging through metabolic dysregulationJoint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance.A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury after ischemia-reperfusion in the mouse.The role of ADAM17 in metabolic inflammation.Insulin resistance and atherosclerosis: convergence between metabolic pathways and inflammatory nodes.Tick-tock: is your cardiometabolic risk on the clock?MicroRNAs in vascular aging and atherosclerosis.miR-146a is modulated in human endothelial cell with aging.Effect of ezetimibe on cholesterol absorption and lipoprotein composition in diabetes and metabolic syndrome.Oral hypoglycemic agents and the heart failure conundrum: Lessons from and for outcome trials.A genetic marker of hyperuricemia predicts cardiovascular events in a meta-analysis of three cohort studies in high risk patients.Serum glucocorticoid inducible kinase (SGK)-1 protects endothelial cells against oxidative stress and apoptosis induced by hyperglycaemia.Regulation of TIMP3 in diabetic nephropathy: a role for microRNAs.Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha.MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1.Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis.MiR-216a: a link between endothelial dysfunction and autophagy.Effects of Dipeptidyl Peptidase 4 Inhibitors and Sodium-Glucose Linked coTransporter-2 Inhibitors on cardiovascular events in patients with type 2 diabetes mellitus: A meta-analysis.TIMP3 overexpression in macrophages protects from insulin resistance, adipose inflammation, and nonalcoholic fatty liver disease in mice.Serum- and Glucocorticoid-Inducible Kinase 1 Delay the Onset of Endothelial Senescence by Directly Interacting with Human Telomerase Reverse Transcriptase.FoxO1 regulates asymmetric dimethylarginine via downregulation of dimethylaminohydrolase 1 in human endothelial cells and subjects with atherosclerosis.Iron status in obesity: An independent association with metabolic parameters and effect of weight loss.Transgenic mice overexpressing human G972R IRS-1 show impaired insulin action and insulin secretion.IL-21 is a major negative regulator of IRF4-dependent lipolysis affecting Tregs in adipose tissue and systemic insulin sensitivity.
P50
Q21133747-63DE0B45-3A29-45F7-B7FC-6A0B079EA061Q24605364-AAB4F438-8E73-4577-B45D-14FDC815F2DBQ24612380-AE4506AE-45AF-4A23-A425-BA19C14D4456Q28200997-2962EE50-F850-40B3-9E72-A514AF71ED13Q30495814-165812B6-7A97-4ACD-9153-E7C5338CBF23Q30586693-A2EC0895-9785-4333-AF17-2577D80DD5AFQ33740199-3EDAFDAE-8E74-490C-9BDF-D48E40691ACAQ33813006-8C38B846-9831-4B7E-8C85-5A6B3D2EB511Q33933560-DAA8BA03-56D7-40FE-B07F-57B65A0889C0Q34110542-F2E768C6-B0D6-47F7-9026-A6EDC2D9CD3FQ34615287-30C29DE4-CD6A-4806-B127-DFA71CF8EC8FQ34954938-0F7DD595-57CA-4BE8-9FE9-C85FB3DC987EQ35182999-26684A76-EE58-4480-B01B-70E3F9108E3FQ35561058-ED24FA44-9191-4F5E-86FC-EEA60D074B09Q35847003-616E0AC0-EA52-4211-840A-44B143C15353Q36106449-DD96D760-3B36-4FC8-B52F-AB7A481ED464Q36240893-FB8AFF1E-1D0D-49D0-B44A-58EE1F246D14Q36487212-8CE4218C-5452-43A7-97FA-CC20C814F098Q37692892-01389C3A-6878-434B-B6BA-58A201492F67Q38079339-FA558F40-BB87-4F98-8D27-1A03A04DEA7DQ38124366-2C618C5D-CB8E-44EB-B669-1F6E31F0DF7DQ38176345-1C6CEDAC-6F45-4E9F-84DE-829037060498Q38200421-09765B70-9CCC-4202-B5A0-E93006CBBAE2Q38335771-0B0AD5AC-3BA3-49EE-A89E-89E9EA869D7FQ38346990-78A7468F-A120-4196-8704-25A7BB6CE8C5Q38545421-C5007020-87BB-4D01-9D0E-2971659F22F5Q38647829-190C2CC3-E941-46BF-8F34-D163EB914268Q38981642-2F4D26D6-7378-43E8-9932-AE3B59771EABQ39135585-DCA7548E-1B93-4C1A-A6A5-C650F9E5B319Q39704977-54FDCEDB-34E9-4080-8880-4209C25671BDQ39794127-28A96913-600D-443F-977F-3FFF455E5039Q40017680-D970B1E1-141D-40BE-8ADD-0D76349D22AAQ40138320-5C997A03-65CF-4A82-99BC-0073B5C75EC2Q40661827-D318CC42-796D-4236-B5BD-A61EF8947154Q40666812-BA480077-D7BA-4D2E-9A12-DC037DBD2A0DQ40673875-73B2C524-9041-46F4-AD85-7CFF0E3D8EA6Q41081128-0196781A-A460-4B09-9A2D-139E12F9F6A7Q41113937-C476E736-2A66-4600-8320-68AFF2664CDEQ41910421-9EB60B75-EB21-4EC0-8652-C3924244AD53Q42808014-A0FF5B52-B08E-46F1-B066-28F9A9D778EF
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Massimo Federici
@ast
Massimo Federici
@en
Massimo Federici
@es
Massimo Federici
@nl
type
label
Massimo Federici
@ast
Massimo Federici
@en
Massimo Federici
@es
Massimo Federici
@nl
prefLabel
Massimo Federici
@ast
Massimo Federici
@en
Massimo Federici
@es
Massimo Federici
@nl
P106
P1153
7006237353
P21
P31
P496
0000-0003-4989-5194